Literature DB >> 27364099

Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.

Manuela Mejia1, Colleen McNicholas1, Tessa Madden1, Jeffrey F Peipert2.   

Abstract

OBJECTIVE: This study aims to evaluate the effect of baseline bleeding patterns on rates of amenorrhea reported at 12 months in levonorgestrel (LNG) 52 mg intrauterine system (IUS) users. We also assessed the effect of baseline bleeding patterns at 3 and 6 months postinsertion. STUDY
DESIGN: In this secondary analysis of the Contraceptive CHOICE Project, we included participants who had an LNG-IUS inserted within 1 month of enrollment and continued use for 12 months. Using 12-month telephone survey data, we defined amenorrhea at 12 months of use as no bleeding or spotting during the previous 6 months. We used chi-square and multivariable logistic regression to assess the association of baseline bleeding pattern with amenorrhea while controlling for confounding variables.
RESULTS: Of 1802 continuous 12-month LNG-IUS users, amenorrhea was reported by 4.9%, 14.8% and 15.4% of participants at 3, 6 and 12 months, receptively. Participants with light baseline bleeding or short duration of flow reported higher rates of amenorrhea at 3 and 6 months postinsertion (p<.03), while LNG-IUS users with heavy or prolonged flow were less likely to report amenorrhea at 3 and 6 months (p<.03). In a multivariable analysis, participants with self-reported heavy bleeding at baseline were less likely to report amenorrhea at 12 months than those who reported moderate bleeding (ORadj, 0.36; 95% CI, 0.16-0.69).
CONCLUSION: Women with heavier menstrual bleeding are less likely than women with moderate flow to report amenorrhea following 12 months of LNG-IUS use. IMPLICATIONS: Baseline heavy menstrual flow reduces the likelihood of amenorrhea with LNG-IUS use, information that could impact contraceptive counseling. Anticipatory counseling can improve method satisfaction and continuation, an important strategy to continue to reduce unintended pregnancy and abortion rates.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amenorrhea; IUD; IUS; Intrauterine device; Intrauterine system; LARC

Mesh:

Substances:

Year:  2016        PMID: 27364099      PMCID: PMC5077249          DOI: 10.1016/j.contraception.2016.06.013

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  20 in total

1.  The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology.

Authors:  V Phillips; C T Graham; S Manek; W G McCluggage
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  Morphologic changes in the endometrium associated with the use of the mirena coil: a retrospective study of 106 cases.

Authors:  Rahul K Hejmadi; Shalini Chaudhri; Raji Ganesan; Terence P Rollason
Journal:  Int J Surg Pathol       Date:  2007-04       Impact factor: 1.271

3.  Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.

Authors:  J Suvisaari; P Lähteenmäki
Journal:  Contraception       Date:  1996-10       Impact factor: 3.375

4.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

5.  The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.

Authors:  Gina M Secura; Jenifer E Allsworth; Tessa Madden; Jennifer L Mullersman; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2010-06-11       Impact factor: 8.661

Review 6.  A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women.

Authors:  Anh Dinh; Intira Sriprasert; Alistair R Williams; David F Archer
Journal:  Contraception       Date:  2015-01-14       Impact factor: 3.375

7.  Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.

Authors:  I den Tonkelaar; B J Oddens
Journal:  Contraception       Date:  1999-06       Impact factor: 3.375

8.  Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies.

Authors:  Jeffrey Jensen; Diana Mansour; Eeva Lukkari-Lax; Pirjo Inki; Karin Burock; Ian S Fraser
Journal:  Contraception       Date:  2012-10-04       Impact factor: 3.375

9.  Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women.

Authors:  Alison Edelman; Robyn Lew; Carrie Cwiak; Mark Nichols; Jeffrey Jensen
Journal:  Contraception       Date:  2007-04-26       Impact factor: 3.375

10.  The burden of uterine fibroids for African-American women: results of a national survey.

Authors:  Elizabeth A Stewart; Wanda K Nicholson; Linda Bradley; Bijan J Borah
Journal:  J Womens Health (Larchmt)       Date:  2013-09-14       Impact factor: 2.681

View more
  1 in total

1.  Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis.

Authors:  Jill E Sergison; Lauren Y Maldonado; Xiaoming Gao; David Hubacher
Journal:  Am J Obstet Gynecol       Date:  2018-12-07       Impact factor: 8.661

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.